Even as researchers search for biomarkers to forecast ketamine response, clinicians come across them selves with a conundrum: Which patients should really start with IV ketamine, and which with Spravato? And how do the two compare head to head in genuine response to treatment? Chronic neuropathic pain arises from a https://wardk813eda2.mybuzzblog.com/profile